# Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products

> **NCT05713214** · — · RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Relapsed Hematologic Malignancy
- Refractory Hematologic Malignancy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05713214
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-08
- **Primary completion:** 2052-12-01
- **Final completion:** 2052-12-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05713214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05713214, "Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05713214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*